← Eichor
Study identifier: NCT07220447 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

Condition: Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm  ·  Sponsor: City of Hope Medical Center

PhaseEARLY_Phase 1
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This clinical trial tests the feasibility, best dose, and effectiveness of L-theanine for supporting relaxation and mood among cancer patients in surveillance. L-theanine is a substance found in the leaves of green tea with potential to enhance mental health and well-being. It works by increasing certain chemicals within the body that have been associated with stress reduction, mood stabilization, and improved cognitive performance.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (4)

City of Hope Medical CenterDuarte, California, United StatesRecruiting
City of Hope SeacliffHuntington Beach, California, United StatesNot Yet Recruiting
City of Hope at Irvine LennarIrvine, California, United StatesNot Yet Recruiting
City of Hope at Irvine Sand CanyonIrvine, California, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07220447